Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Blood (2019) 134 (Supplement_1): 4028.

https://doi.org/10.1182/blood-2019-130223

Published: 2019

Journal Articles

High Prevalence of PPM1D Mutations in Therapy-Related AML/MDS Is Due to Context-Specific Clonal Hematopoiesis

Joanne Hsu, BS, Tajhal Dayaram, Ayala Tovy, PhD, Etienne De Braekeleer, PhD MSc, Mira Jeong, PhD, Jason H. Rogers, MS, Feng Wang, PhD, Jianhua Zhang, PhD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, George S. Vassiliou, Andrew Futreal, PhD, Lawrence Donehower, Koichi Takahashi, MD, Margaret Goodell, PhD

Blood (2018) 132 (Supplement 1): 746.

https://doi.org/10.1182/blood-2018-99-115007

Published: 2018

Journal Articles

Myeloid Malignancies Following Luminal Gastrointestinal Cancer: High Incidence of Deletion 5q and DNTM3A Mutations

Zachary D. Epstein-Peterson, MD, Sean M. Devlin, PhD, Eytan M. Stein, MD, Virginia M. Klimek, MD, Leonard B. Saltz, MD, Martin S. Tallman, MD

Blood (2017) 130 (Supplement 1): 1309.

https://doi.org/10.1182/blood.V130.Suppl_1.1309.1309

Published: 2017

Journal Articles

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Nobuyuki Kabasawa, MD, Bungo Saito, MD PhD, Yohei Sasaki, MD, Shotaro Shimada, MD, Maasa Abe, MD, So Murai, MD, Yuta Baba, MD, Megumi Watanuki, MD, Yukiko Kawaguchi, MD, Nana Arai, MD, Shun Fujiwara, MD, Hiroyuki Tsukamoto, MDPhD, Yui Uto, MD PhD, Hirotsugu Ariizumi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2017) 130 (Supplement 1): 2850.

https://doi.org/10.1182/blood.V130.Suppl_1.2850.2850

Published: 2017

Journal Articles

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

Eytan M. Stein, MD, Vipul Pareek, MD, David Kudlowitz, Dan Douer, MD, Martin S Tallman, MD

Blood (2012) 120 (21): 1453.

https://doi.org/10.1182/blood.V120.21.1453.1453

Published: 2012

Journal Articles

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study

Blood (2010) 116 (21): 992.

https://doi.org/10.1182/blood.V116.21.992.992

Published: 2010

Journal Articles

The HMGA1a-STAT3 axis: an “Achilles Heel” for Hematopoietic Malignancies Overexpressing HMGA1a?

Linda Resar, MD, Joelle Hillion, Ph.D., Surajit Dhara, Ph.D., Takita Felder Sumter, Ph.D., Mita Mukherjee, Ph.D., Francescopaolo Di Cello, Ph.D., Amy Belton, Ph.D., James Turkson, Ph.D., Souyma Jaganathan, Ph.D., Linzhao Cheng, Ph.D., Zhaohui Ye, B.S., Yingwei Lin, MD, PhD, Peter D. Aplan, MD, Richard Jove, Jeanne Kowalski, Kelsey Wertzler, B.S., Ray Reeves, Ph.D., Ossama Elbahlouh, M.D., Raka Bhattacharya, Ph.D.

Blood (2008) 112 (11): 3810.

https://doi.org/10.1182/blood.V112.11.3810.3810

Published: 2008

Journal Articles

Cause-Specific Mortality and Second Cancer Incidence after Non-Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study.

Elizabeth C. Bluhm, MD, MPH, Cecile Ronckers, PhD, Robert J. Hayashi, MD, Joseph P. Neglia, MD, MPH, Ann C. Mertens, PhD, Anna T. Meadows, MD, Pauline A. Mitby, MS, Marilyn Stovall, PhD, Leslie L. Robison, PhD, Peter D. Inskip, ScD

Blood (2007) 110 (11): 3579.

https://doi.org/10.1182/blood.V110.11.3579.3579

Published: 2007

Journal Articles

Marqibo (Vincristine Sulfate Liposomes Injection (OPTISOME™) Demonstrates Activity in Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma.

M. Alma Rodriguez, MD, Jane N. Winter, MD, Biao Lu, PhD, Gary Huang, MD, Gavin S. Choy, PharmD, Steven R. Deitcher, MD

Blood (2007) 110 (11): 4466.

https://doi.org/10.1182/blood.V110.11.4466.4466

Published: 2007

Journal Articles

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Apostolia-Maria Tsimberidou, MD, PhD, William G. Wierda, M.D., Ph.D., Susan O’Brien, M.D., William W. Plunkett, M.D., Thomas J. Kipps, M.D., Jennifer R. Brown, M.D., Ph.D, Susan Lerner, M.S., Hagop Kantarjian, M.D., Michael J. Keating, M.D.

Blood (2006) 108 (11): 2825.

https://doi.org/10.1182/blood.V108.11.2825.2825

Published: 2006

Journal Articles

Oxaliplatin as Single Agent or in Combination in Chronic Lymphocytic Leukaemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Alfredo Molteni, MD, Enrica Morra, MD

Blood (2006) 108 (11): 4982.

https://doi.org/10.1182/blood.V108.11.4982.4982

Published: 2006

Journal Articles

Characteristics and Outcome of Therapy-Related MDS Developing after Primary Cancer in Children.

R. Ammann, M. Zecca, D. Betts, J. Harbott, M. Trebo, H. Hasle, M. van den Heuvel-Eibrink, J. Starý, E. Bergstraesser, C. Peters, J. Vormoor, U. Kontny, B. Strahm, U. Duffner, P. Noellke, F. Locatelli, C. M. Niemeyer

Blood (2005) 106 (11): 2514.

https://doi.org/10.1182/blood.V106.11.2514.2514

Published: 2005

NARROW

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

High Prevalence of PPM1D Mutations in Therapy-Related AML/MDS Is Due to Context-Specific Clonal Hematopoiesis

Myeloid Malignancies Following Luminal Gastrointestinal Cancer: High Incidence of Deletion 5q and DNTM3A Mutations

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Acute Leukemias Following a Diagnosis of Colorectal Cancer: Are They Therapy-Related?

The Genotype of MLH1 Is An Independent Predictor of Outcome In Diffuse Large B-Cell Lymphoma Treated with R-CHOP: a Training-Validation Study

The HMGA1a-STAT3 axis: an “Achilles Heel” for Hematopoietic Malignancies Overexpressing HMGA1a?

Cause-Specific Mortality and Second Cancer Incidence after Non-Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study.

Marqibo (Vincristine Sulfate Liposomes Injection (OPTISOME™) Demonstrates Activity in Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma.

Combination of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Richter’s Syndrome and Fludarabine-Refractory Chronic Lymphocytic Leukemia.

Oxaliplatin as Single Agent or in Combination in Chronic Lymphocytic Leukaemia (CLL).

Characteristics and Outcome of Therapy-Related MDS Developing after Primary Cancer in Children.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only